NCT05644496View on ClinicalTrials.gov

ZYNRELEF for Pain Management in Total Knee Arthroplasty

PHASE4RecruitingINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

March 9, 2023

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2027

Conditions
Post Operative PainOsteoarthritis, Knee
Interventions
DRUG

Bupivacaine-Meloxicam 400 Mg-12 Mg/14 mL Injectable Solution, Extended Release

Instillation of the drug into the knee joint capsule and surrounding tissues after placing the knee prosthesis and before close of the surgical wound

Trial Locations (1)

33146

RECRUITING

Doctors Hospital, Miami

All Listed Sponsors
lead

Baptist Health South Florida

OTHER